Effects of Vaginal Estrogens on Serum Estradiol Levels in Postmenopausal Breast Cancer Survivors and Women at Risk of Breast Cancer Taking an Aromatase Inhibitor or a Selective Estrogen Receptor Modulator

Lignende værker

• Challenges of measuring accurate estradiol levels in aromatase inhibitor‐treated postmenopausal breast cancer patients on vaginal estrogen therapy
  af: Niravath, Polly, et al.
  Udgivet: (2017)
• Relationship Between Plasma Estradiol Levels and Estrogen-Responsive Gene Expression in Estrogen Receptor–Positive Breast Cancer in Postmenopausal Women
  af: Dunbier, Anita K., et al.
  Udgivet: (2010)
• Endocrinology and hormone therapy in breast cancer: Aromatase inhibitors versus antioestrogens
  af: Howell, Anthony, et al.
  Udgivet: (2004)
• Deficits in plasma oestradiol measurement in studies and management of breast cancer
  af: Dowsett, Mitch, et al.
  Udgivet: (2005)
• Impact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancer
  af: Pfeiler, G, et al.
  Udgivet: (2013)